Medigene announces participation at six upcoming investor and scientific conferences
Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at six upcoming investor and scientifi…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at six upcoming investor and scientifi…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX) gibt ihre Teilnahme an sechs bevorstehenden Investoren- und Wissensc…
- Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharm…
Synergien zwischen den rekombinanten T-Zell-Technologien von Medigene und den "self-delivering" RNAi-Technologien von RX…
Monetization of last remaining legacy product essentially completes Medigene's transformation into a pure-play, clinical…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX) gibt ihre Teilnahme an sechs bevorstehenden Wissenschafts-, Investor…
Medigene AG (MDG1, Frankfurt, Prime Standard, TecDAX) announces that a scientific article on a method to identify T cell…
The Executive Management Board of Medigene AG (FSE: MDG1, Prime Standard, TecDAX) with the approval of the Company's Sup…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX), will demonstrate the use of its automated high-throughput screening (HT…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX) wird auf dem kommenden CAR-TCR Summit vom 5.-8. September in Boston,…